Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Action antagonists |
Mechanism CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists), TBXA2R antagonists(Thromboxane A2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H33ClN6O5S2 |
InChIKeyZEZUDOUQZAREDI-UHFFFAOYSA-N |
CAS Registry179102-65-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | - | - | |
Asthma | Phase 1 | Europe | - | - |
Rhinitis, Allergic | Phase 1 | Europe | - | - |
Rhinitis, Allergic | Phase 1 | - | - |